We are live on
!
Find out more
MJRIC
Mogy Joel R Investment Counsel Portfolio holdings
AUM
$1.75B
1-Year Est. Return
17.81%
This Fund
S&P 500
This Quarter
Est. Return
-2.55%
1 Year Est. Return
+17.81%
3 Year Est. Return
+97.31%
5 Year Est. Return
+136.49%
10 Year Est. Return
+593.66%
AUM
$1.19B
AUM Growth
-$69.5M
(-5.5%)
Cap. Flow
-$28.8M
Cap. Flow
% of AUM
-2.42%
Top 10 Holdings %
Top 10 Hldgs %
49.95%
Holding
116
New
1
Increased
12
Reduced
63
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$9.62M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$9.53M |
| 3 |
MSCI
MSCI
|
+$1.88M |
| 4 |
O'Reilly Automotive
ORLY
|
+$1.63M |
| 5 |
AutoZone
AZO
|
+$1.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$14.6M |
| 2 |
VanEck Biotech ETF
BBH
|
+$5.76M |
| 3 |
Cisco
CSCO
|
+$4.26M |
| 4 |
Apple
AAPL
|
+$2.63M |
| 5 |
Brookfield
BN
|
+$2.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.34% |
| 2 | Healthcare | 12.16% |
| 3 | Consumer Discretionary | 11.69% |
| 4 | Financials | 11.18% |
| 5 | Communication Services | 10.85% |
Similar funds
SFI
DF
CIP
VCM
PAIM
RIA
NM
NMC
Mogy Joel R Investment Counsel's Q3 2023 Portfolio in Review
As of Q3 2023, Mogy Joel R Investment Counsel held 116 positions worth $1.19B, down 5.5% from $1.26B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Mogy Joel R Investment Counsel's Q3 2023 filing shows 1 new, 12 increased, 63 reduced and 11 closed positions. Its largest new stake was Novo Nordisk: 108,184 shares worth $9.84M. The largest sale was Johnson & Johnson, an estimated $14.6M.
By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 40% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Mogy Joel R Investment Counsel's largest Q3 2023 buy was Novo Nordisk: 108,184 shares worth $9.84M.
- Mogy Joel R Investment Counsel added most to Eli Lilly in Q3 2023, an estimated $9.62M increase.
- Mogy Joel R Investment Counsel's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $14.6M.
- Mogy Joel R Investment Counsel fully exited VanEck Biotech ETF in Q3 2023, selling an estimated $5.76M.
- Mogy Joel R Investment Counsel's ten largest holdings make up 50% of its $1.19B portfolio in Q3 2023.
- Mogy Joel R Investment Counsel opened 1 new position and closed 11 in Q3 2023.
- Mogy Joel R Investment Counsel's portfolio value fell 5.5% quarter-over-quarter to $1.19B.
Based on Mogy Joel R Investment Counsel's 13F filing for Q3 2023, filed 1 Nov 2023.